This Month in the Journal  by Ashkenas, John
Am. J. Hum. Genet. 64:i–ii, 1999
i
This Month in the Journal
Trinucleotide-repeat (TNR) expansions cause diverse
human disorders, by several different molecular mech-
anisms. These mechanisms—or at least the questions
that surround them—have begun to come into focus, as
shown by the reviews in this issue. Paulson (p. 339)
discusses the so-called polyQ diseases, the largest class
of TNR disorders, in which long tracts of polyglutamine
are expressed in disease-associated proteins. He relates
the ongoing controversies about the pathological role of
polyglutamine-containing nuclear inclusions in brains of
people with Huntington disease or with various spino-
cerebellar ataxias, and he considers the potential role of
protein chaperones in these diseases. Sinden (p. 346)
shows how the various disease-associated classes of
TNRs affect DNA structure, and he addresses possible
mechanisms to account for repeat tract instability at
meiosis. Sutherland and Richards (p. 354) discuss chro-
mosome fragility: the best-known fragile sites are TNR
expansions that can lead to X-linked retardation, but
fragile sites are also common on autosomes, and not all
of them contain simple sequence repeats. A TNR ex-
pansion in theDM gene is also known to cause myotonic
dystrophy, a curious finding because the repeat occurs
in an expressed but untranslated portion of the gene.
Timchenko (p. 360) argues that this expansion interferes
with protein-mRNA interactions that are required for
normal muscle-cell function. Finally, Knight et al. (p.
365) discuss Friedreich ataxia, an unusual condition as-
sociated with an intronic TNR expansion. The discovery
of a yeast model for the disease has revealed a previously
unsuspected defect in cellular (particularly mitochon-
drial) iron transport.
Angelman Syndrome in Two Large Families, by
Ohta et al. (p. 385)
Two papers by Ohta and colleagues focus on the reg-
ulation of transcriptional silencing at the two well-
studied imprinted loci on 15q that are associated with
Angelman syndrome (AS) and Prader-Willi syndrome
(PWS). AS occurs when the putative ubiquitin ligase gene
UBE3A, which is normally expressed only from the ma-
ternal chromosome, fails to be expressed at all. Null
mutations on the maternal UBE3A allele can account
for some such cases, but in other AS individuals the
defect is in the regulation of the imprinted status. An
AS imprinting center (IC) had been defined that is re-
quired for the silenced grandpaternal allele to be reac-
tivated as it passes through the maternal germ line. As
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the authors had reported previously, this “paternal to
maternal switch” does not occur on chromosomes with
short deletions around the SNRPN locus. Now, they
report two AS IC deletions that have allowed them to
refine the critical interval to a 1.15-kb region ∼30 kb
from SNRPN.
Imprinting Mutations in Prader-Willi Syndrome, by
Ohta et al. (p. 397)
The effects of IC defects in PWS are analogous to those
in AS, although the parental origins are inverted. Hence,
passage through the paternal germ line normally reac-
tivates the silenced grandmaternal genes on 15q; dele-
tions in a critical control region prevent the reactivation
of the expression of one or more clinically relevant genes.
This epigenetic effect is seen when the chromosome that
lacks the PWS IC derives from the paternal grandmother.
Ohta et al. have mapped several such deletions, and they
now show that a necessary part of the regulatory locus
occurs in a 4.3-kb region surrounding the promoter and
first exon of SNRPN. The authors also describe three
sporadic instances of PWS IC defects in which no such
deletion or other mutation could be found. They spec-
ulate that random failure in the reactivation of the
grandmaternal allele may lead to some cases of PWS,
independent of any DNA sequence changes.
Tau Mutations in FTD Patients, by Rizzu et al.
(p. 414)
The tau proteins are a set of closely related microtubule-
associated proteins that promote tubulin assembly in
vitro and that stabilize cellular microtubule arrays in
vivo. These proteins, the products of an alternatively
spliced RNA from a single locus, have been associated
with the progression of Alzheimer disease (AD), because
they form fibrils in the amyloid plaques in degenerating
AD brain tissues. TAU is also implicated more directly
in another hereditary neurodegeneration syndrome,
frontotemporal dementia and parkinsonism linked to
chromosome 17 (FTDP-17). Rizzu and coworkers have
screened for TAU mutations in 90 people with fronto-
temporal dementia. Among 30 independent familial
cases, Rizzu et al. report five likely disease alleles, of
which two are novel. By expressing wild-type and mu-
tant forms of tau in bacteria, these authors show that
purified mutant tau fails to promote microtubule nucle-
ation or growth. The dominant inheritance of FTDP-17
may be explained if these variants have a similar effect
in the axon. The unassembled tau proteins may be par-
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ticularly prone to formation of fibrils during or after
neuronal death.
Alu Insertion in FGFR2 in Apert Syndrome, by
Oldridge et al. (p. 446)
The FGFR2 gene is complex with regard to both its
expression and the clinical effects of different mutations.
The FGFR2 mRNA is alternatively spliced to encode
either the keratinocyte growth-factor receptor (KGFR),
normally expressed in epithelial cells, or BEK, a receptor
tyrosine kinase found in mesenchymal cells. Mutations
that affect one or both of these gene products lead to
five distinct human dysmorphology syndromes that af-
fect the skull and other bones, such as the digits. One
of these, Apert syndrome, has been associated in every
case with point mutations mapping to an extremely short
(two amino acids long) region of the FGFR2 proteins.
Now, Oldridge et al. have found two counterexamples
to this rule. Both of the new alleles result from Alu-
element insertions located somewhat 3′ to the critical
dipeptide region. The finding that one of these mutations
leads to the inappropriate expression of KGFR in fibro-
blasts led Oldridge and coworkers to examine the ex-
pression of Kgfr and Bek in the developing mouse limb.
On the basis of this analysis, they present a model to
explain the effect of ectopic KGFR expression on the
separation of digits.
Identification of a Severe Mutation in hGALE, by
Wohlers et al. (p. 462)
Interconversion of charged sugar molecules is required
for cellular biosynthesis of complex glycolipids and
glycoproteins. The UDP-galactose-4-epimerase (GALE)
protein catalyzes one such interconversion, the epim-
erization of galactose to glucose within the UDP-galac-
tose (UDP-Gal) or UDP-N-acetylglucosamine (UDP-
GalNAc) molecules. Missense mutations in GALE are
known to cause a mild “peripheral” form of galacto-
semia, in which blood cells lack, but other tissues retain,
measurable enzymatic activity. Wohlers and colleagues
now show that, in two unrelated families, children with
the severe “generalized” form of the disease are ho-
mozygous for a novel GALE missense allele. Studies of
this and other alleles expressed in yeast indicate that the
sequence changes lead to loss of activity and/or unstable
folding of GALE. However, the clinical phenotype does
not always correlate with the activity seen in yeast. The
authors also show that GALE mutations can affect ac-
tivity differently, depending on whether UDP-Gal or
UDP-GalNAc is used as a substrate, although only the
former substrate usually is tested in galactosemic
families.
DNA Variation and Mutation of X Chromosome, by
Anagnostopoulos et al. (p. 508)
Here, Anagnostopoulos and coworkers explore the use
of a DNA-mismatch detection system in the study of
human variation. The method compares fluorescence-
labeled PCR products amplified from one genome with
an unlabeled reference sequence to which it is hy-
bridized. Sequence divergences—including nucleotide
changes, insertions, or deletions—allow the labeled
products to be cleaved chemically, so that the size of the
cleaved products can be used to pinpoint the original
mismatch, without sequencing. Assuming only that the
locations of these PCR products are well mapped on the
chromosome, such data are readily used to derive hap-
lotypes. Anagnostopoulos et al. have now applied this
approach to a 5-Mb stretch of the X chromosome in 23
men from three distinct ethnic groups, and they also have
compared their reference sequence with X-linked DNA
from a male chimpanzee. They report the relative fre-
quency of different classes of sequence changes that have
occurred during speciation and human migration. This
approach also can be adapted to generate long and de-
tailed haplotypes that may be useful in following the
evolution of autosomal genes.
Biallelic and Microsatellite Markers in Mapping, by
Xiong and Jin (p. 629)
Xiong and Jin consider the use of likelihood-based dis-
equilibrium mapping and transmission-disequilibrium
mapping, in genomewide screens for disease genes. They
apply these methods to two classes of polymorphic
marker data: multiallelic microsatellite-repeat polymor-
phisms and biallelic single-nucleotide polymorphisms
(SNPs). With both classes of data, they found that the
power and precision of the screens are strongly affected
by the age of the disease allele and by the population
frequency of marker alleles linked to it. The authors
indicate that microsatellite markers often will be more
powerful, because some rarer alleles may be found at
such loci, but a sufficiently dense array of SNPs could
overcome this advantage. SNPs are also less susceptible
to mutation than are microsatellites; therefore, SNPs
may be more suited to fine-structure mapping, in which
the rate of recombination between markers may be com-
parable to the rate at which microsatellite lengths
mutate.
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